Form 4 for OPRX OptimizeRx Corp
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-02 · accession 0001213900-21-063363 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-02 | OPRX | Paramore Miriam J | Pres AND CSO | S - Sale+OE | $61.48 | -3,558 | 71.0K | -5% | -$218.7K |
| D | 2021-12-03 | 2021-12-02 | OPRX | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | +3,558 | 74.6K | +5% | +$26.7K |
| D | 2021-12-03 | 2021-12-02 | OPRX | Paramore Miriam J | Pres AND CSO | M - OptEx | $7.51 | -3,558 | 90.8K | -4% | -$26.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Pursuant to 10B5-1 Plan | 2021-12-02 | S | D | 3,558 | $61.48 | 71,049 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock | 2021-12-02 | M | A | 3,558 | $7.51 | 74,607 | D | — | — | |
| 3 | Derivative | Stock Option | 2021-12-02 | M | D | 3,558 | $7.51 | 90,760 | D | $7.51 · 2020-12-31 to 2025-03-11 | 3,558 Common Stock |